The DOI matches its Crossref record; 225 of the 225 references it cites were found in a registry or an index.
Ferroptosis Mechanisms Involved in Neurodegenerative Diseases
Open accessAbstract
Ferroptosis is a type of cell death that was described less than a decade ago. It is caused by the excess of free intracellular iron that leads to lipid (hydro) peroxidation. Iron is essential as a redox metal in several physiological functions. The brain is one of the organs known to be affected by iron homeostatic balance disruption. Since the 1960s, increased concentration of iron in the central nervous system has been associated with oxidative stress, oxidation of proteins and lipids, and cell death. Here, we review the main mechanisms involved in the process of ferroptosis such as lipid peroxidation, glutathione peroxidase 4 enzyme activity, and iron metabolism. Moreover, the association of ferroptosis with the pathophysiology of some neurodegenerative diseases, namely Alzheimer’s, Parkinson’s, and Huntington’s diseases, has also been addressed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
CHEN, L., LI, X., LIU, L., YU, B., XUE, Y., & LIU, Y. (2015) · Oncology Reports · doi:10.3892/or.2015.3712 · Cited by 279
RetractedRETRACTED: Characterising the spatial and temporal brain metal profile in a mouse model of tauopathy
Rao, S. S., Lago, L., de Vega, R. G., Bray, L., Hare, D. J., Clases, D., Doble, P., & Adlard, P. A. (2019) · Metallomics · doi:10.1039/c9mt00267g · Cited by 28
RetractedFerroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Stockwell, B. R., Friedmann Angeli, J. P., Bayir, H., Bush, A. I., Conrad, M., Dixon, S. J., Fulda, S., Gascón, S., Hatzios, S. K., Kagan, V. E., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.021 · Cited by 7,695
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803 · cited 2×
“Chalcones 14a–c were shown to inhibit β-amyloid aggregation, and in addition, protect neural cells against toxicity induced by Aβ aggregation and from erastin and RSL3-induced ferroptosis in human neuroblastoma SH-SY5Y cells [160].”
BackgroundQuerfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition
Doll, S., Proneth, B., Tyurina, Y. Y., Panzilius, E., Kobayashi, S., Ingold, I., Irmler, M., Beckers, J., Aichler, M., Walch, A., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2239 · Cited by 4,293
Ferroptosis: past, present and future
Li, J., Cao, F., Yin, H.-L., Huang, Z.-J., Lin, Z.-T., Mao, N., Sun, B., & Wang, G. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2298-2 · Cited by 4,171
Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice
Friedmann Angeli, J. P., Schneider, M., Proneth, B., Tyurina, Y. Y., Tyurin, V. A., Hammond, V. J., Herbach, N., Aichler, M., Walch, A., Eggenhofer, E., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3064 · Cited by 3,732
Ferroptosis: process and function
Xie, Y., Hou, W., Song, X., Yu, Y., Huang, J., Sun, X., Kang, R., & Tang, D. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.158 · Cited by 3,727
Neuropathological alterations in Alzheimer disease
Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345 · cited 2×
“Proteolytic cleavage of the β-amyloid precursor protein (APP) to form theβ-amyloid peptide (Aβ) is related to the pathogenesis of AD because APP mutations that influence this process induce familial AD or decrease the risk of AD [145].”
BackgroundFSP1 is a glutathione-independent ferroptosis suppressor
Doll, S., Freitas, F. P., Shah, R., Aldrovandi, M., da Silva, M. C., Ingold, I., Goya Grocin, A., Xavier da Silva, T. N., Panzilius, E., Scheel, C. H., et al. (2019) · Nature · doi:10.1038/s41586-019-1707-0 · Cited by 3,341
Ferroptosis: Death by Lipid Peroxidation
Yang, W. S., & Stockwell, B. R. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.10.014 · Cited by 3,088
Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis
Kagan, V. E., Mao, G., Qu, F., Angeli, J. P. F., Doll, S., Croix, C. S., Dar, H. H., Liu, B., Tyurin, V. A., Ritov, V. B., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2238 · Cited by 3,029
Non-motor symptoms of Parkinson's disease: diagnosis and management
Chaudhuri, K. R., Healy, D. G., & Schapira, A. H. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70373-8 · Cited by 2,807
Lane, C. A., Hardy, J., & Schott, J. M. (2018) · European Journal of Neurology · doi:10.1111/ene.13439 · Cited by 2,616
The molecular machinery of regulated cell death
Tang, D., Kang, R., Berghe, T. V., Vandenabeele, P., & Kroemer, G. (2019) · Cell Research · doi:10.1038/s41422-019-0164-5 · Cited by 2,549
Epidemiology of Parkinson’s disease
Tysnes, O.-B., & Storstein, A. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1686-y · Cited by 2,414
Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis
Yang, W. S., Kim, K. J., Gaschler, M. M., Patel, M., Shchepinov, M. S., & Stockwell, B. R. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603244113 · Cited by 2,329
Lees, A. J., Hardy, J., & Revesz, T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60492-x · Cited by 1,956
The Role of Oxidative Stress in Parkinson's Disease
Dias, V., Junn, E., & Mouradian, M. M. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130230 · Cited by 1,845
Lipid peroxidation in cell death
Gaschler, M. M., & Stockwell, B. R. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.10.086 · Cited by 1,828
Huntington's disease: from molecular pathogenesis to clinical treatment
Ross, C. A., & Tabrizi, S. J. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70245-3 · Cited by 1,743
Selenium Utilization by GPX4 Is Required to Prevent Hydroperoxide-Induced Ferroptosis
Ingold, I., Berndt, C., Schmitt, S., Doll, S., Poschmann, G., Buday, K., Roveri, A., Peng, X., Porto Freitas, F., Seibt, T., et al. (2018) · Cell · doi:10.1016/j.cell.2017.11.048 · Cited by 1,656
Bates, G. P., Dorsey, R., Gusella, J. F., Hayden, M. R., Kay, C., Leavitt, B. R., Nance, M., Ross, C. A., Scahill, R. I., Wetzel, R., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.5 · Cited by 1,641
-Synuclein in Parkinson's Disease
Stefanis, L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009399 · Cited by 1,446
Samii, A., Nutt, J. G., & Ransom, B. R. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16305-8 · Cited by 1,265
Immunogenic and tolerogenic cell death
Green, D. R., Ferguson, T., Zitvogel, L., & Kroemer, G. (2009) · Nature Reviews Immunology · doi:10.1038/nri2545 · Cited by 1,176
Dexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07264.x · Cited by 1,149
Fricker, M., Tolkovsky, A. M., Borutaite, V., Coleman, M., & Brown, G. C. (2018) · Physiological Reviews · doi:10.1152/physrev.00011.2017 · Cited by 1,108
Ferroptosis is a type of autophagy-dependent cell death
Zhou, B., Liu, J., Kang, R., Klionsky, D. J., Kroemer, G., & Tang, D. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.03.002 · Cited by 1,061
The development of the concept of ferroptosis
Hirschhorn, T., & Stockwell, B. R. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.09.043 · Cited by 1,052
Huntington's disease: a clinical review
Roos, R. A. (2010) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-5-40 · Cited by 1,037
Redox- and non-redox-metal-induced formation of free radicals and their role in human disease
Valko, M., Jomova, K., Rhodes, C. J., Kuča, K., & Musílek, K. (2016) · Archives of Toxicology · doi:10.1007/s00204-015-1579-5 · Cited by 1,022
The chemical basis of ferroptosis
Conrad, M., & Pratt, D. A. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0408-1 · Cited by 1,002
Butterfield, D. A., & Lauderback, C. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00794-3 · Cited by 1,001
Lewerenz, J., Hewett, S. J., Huang, Y., Lambros, M., Gout, P. W., Kalivas, P. W., Massie, A., Smolders, I., Methner, A., Pergande, M., et al. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4391 · Cited by 978
PEBP1 Wardens Ferroptosis by Enabling Lipoxygenase Generation of Lipid Death Signals
Wenzel, S. E., Tyurina, Y. Y., Zhao, J., St. Croix, C. M., Dar, H. H., Mao, G., Tyurin, V. A., Anthonymuthu, T. S., Kapralov, A. A., Amoscato, A. A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.044 · Cited by 950
Insight into the mechanism of ferroptosis inhibition by ferrostatin-1
Miotto, G., Rossetto, M., Di Paolo, M. L., Orian, L., Venerando, R., Roveri, A., Vučković, A.-M., Bosello Travain, V., Zaccarin, M., Zennaro, L., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2019.101328 · Cited by 906
Iron homeostasis and oxidative stress: An intimate relationship
Galaris, D., Barbouti, A., & Pantopoulos, K. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2019.118535 · Cited by 903
Park, E., & Chung, S. W. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-2064-5 · Cited by 890
Transferrin Receptor Is a Specific Ferroptosis Marker
Feng, H., Schorpp, K., Jin, J., Yozwiak, C. E., Hoffstrom, B. G., Decker, A. M., Rajbhandari, P., Stokes, M. E., Bender, H. G., Csuka, J. M., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.049 · Cited by 880
Oxidative stress and Parkinson’s disease
Blesa, J., Trigo-Damas, I., Quiroga-Varela, A., & Jackson-Lewis, V. R. (2015) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2015.00091 · Cited by 878
Hambright, W. S., Fonseca, R. S., Chen, L., Na, R., & Ran, Q. (2017) · Redox Biology · doi:10.1016/j.redox.2017.01.021 · Cited by 851
Parkinson's Disease and Parkinsonism
Hayes, M. T. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.03.001 · Cited by 823
Oxidative Alterations in Alzheimer's Disease
Markesbery, W. R., & Carney, J. M. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00215.x · Cited by 784
Imai, H., & Nakagawa, Y. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01197-8 · Cited by 767
Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons
DiFiglia, M., Sapp, E., Chase, K., Schwarz, C., Meloni, A., Young, C., Martin, E., Vonsattel, J.-P., Carraway, R., Reeves, S. A., et al. (1995) · Neuron · doi:10.1016/0896-6273(95)90346-1 · Cited by 749
The emerging role of ferroptosis in inflammation
Sun, Y., Chen, P., Zhai, B., Zhang, M., Xiang, Y., Fang, J., Xu, S., Gao, Y., Chen, X., Sui, X., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110108 · Cited by 739
The Roles of NRF2 in Modulating Cellular Iron Homeostasis
Kerins, M. J., & Ooi, A. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7176 · Cited by 738
Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis
Zou, Y., Li, H., Graham, E. T., Deik, A. A., Eaton, J. K., Wang, W., Sandoval-Gomez, G., Clish, C. B., Doench, J. G., & Schreiber, S. L. (2020) · Nature Chemical Biology · doi:10.1038/s41589-020-0472-6 · Cited by 734
Chin-Chan, M., Navarro-Yepes, J., & Quintanilla-Vega, B. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00124 · Cited by 707
RSL3 Drives Ferroptosis Through GPX4 Inactivation and ROS Production in Colorectal Cancer
Sui, X., Zhang, R., Liu, S., Duan, T., Zhai, L., Zhang, M., Han, X., Xiang, Y., Huang, X., Lin, H., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01371 · Cited by 703
Muckenthaler, M. U., Galy, B., & Hentze, M. W. (2008) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.28.061807.155521 · Cited by 701
Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis
Fan, Z., Wirth, A.-K., Chen, D., Wruck, C. J., Rauh, M., Buchfelder, M., & Savaskan, N. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.65 · Cited by 692
Do Van, B., Gouel, F., Jonneaux, A., Timmerman, K., Gelé, P., Pétrault, M., Bastide, M., Laloux, C., Moreau, C., Bordet, R., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.05.011 · Cited by 689
Current understanding of iron homeostasis
Anderson, G. J., & Frazer, D. M. (2017) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.117.155804 · Cited by 688
Ferritinophagy-mediated ferroptosis is involved in sepsis-induced cardiac injury
Li, N., Wang, W., Zhou, H., Wu, Q., Duan, M., Liu, C., Wu, H., Deng, W., Shen, D., & Tang, Q. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.08.009 · Cited by 669
HSPB1 as a novel regulator of ferroptotic cancer cell death
Sun, X., Ou, Z., Xie, M., Kang, R., Fan, Y., Niu, X., Wang, H., Cao, L., & Tang, D. (2015) · Oncogene · doi:10.1038/onc.2015.32 · Cited by 666
Metabolic control of cell death
Green, D. R., Galluzzi, L., & Kroemer, G. (2014) · Science · doi:10.1126/science.1250256 · Cited by 647
Nonmotor fluctuations in Parkinson’s disease: Frequent and disabling
Witjas, T., Kaphan, E., Azulay, J. P., Blin, O., Ceccaldi, M., Pouget, J., Poncet, M., & Chérif, A. A. (2002) · Neurology · doi:10.1212/wnl.59.3.408 · Cited by 642
Andrews, N. C., & Schmidt, P. J. (2007) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.031905.164337 · Cited by 642
Mammalian lipoxygenases and their biological relevance
Kuhn, H., Banthiya, S., & van Leyen, K. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.10.002 · Cited by 624
Lipid Peroxidation-Dependent Cell Death Regulated by GPx4 and Ferroptosis
Imai, H., Matsuoka, M., Kumagai, T., Sakamoto, T., & Koumura, T. (2016) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2016_508 · Cited by 623
Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease
Devos, D., Moreau, C., Devedjian, J. C., Kluza, J., Petrault, M., Laloux, C., Jonneaux, A., Ryckewaert, G., Garçon, G., Rouaix, N., et al. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5593 · Cited by 619
Glutathione peroxidase family – an evolutionary overview
Margis, R., Dunand, C., Teixeira, F. K., & Margis‐Pinheiro, M. (2008) · The FEBS Journal · doi:10.1111/j.1742-4658.2008.06542.x · Cited by 610
The redox chemistry of the Alzheimer's disease amyloid β peptide
Smith, D. G., Cappai, R., & Barnham, K. J. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.02.002 · Cited by 608
Dixon, S. J., & Stockwell, B. R. (2019) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055844 · Cited by 577
Ferroptosis and Cancer: Mitochondria Meet the “Iron Maiden” Cell Death
Battaglia, A. M., Chirillo, R., Aversa, I., Sacco, A., Costanzo, F., & Biamonte, F. (2020) · Cells · doi:10.3390/cells9061505 · Cited by 561
Regulation of lipid peroxidation and ferroptosis in diverse species
Conrad, M., Kagan, V. E., Bayir, H., Pagnussat, G. C., Head, B., Traber, M. G., & Stockwell, B. R. (2018) · Genes & Development · doi:10.1101/gad.314674.118 · Cited by 544
Bridges, R. J., Natale, N. R., & Patel, S. A. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01480.x · Cited by 538
Mechanisms of Ferroptosis and Relations With Regulated Cell Death: A Review
Lei, P., Bai, T., & Sun, Y. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00139 · Cited by 532
Choo, Y. S. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh162 · Cited by 515 · cited 1×
“It has been shown that mHTT and the wild version are associated with the outer mitochondrial membrane [224].”
BackgroundHuntington’s Disease: Mechanisms of Pathogenesis and Therapeutic Strategies
Jimenez-Sanchez, M., Licitra, F., Underwood, B. R., & Rubinsztein, D. C. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024240 · Cited by 507
Chen, L., Hambright, W. S., Na, R., & Ran, Q. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.680090 · Cited by 498
Wyttenbach, A. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.9.1137 · Cited by 494
Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles
Eaton, J. K., Furst, L., Ruberto, R. A., Moosmayer, D., Hilpmann, A., Ryan, M. J., Zimmermann, K., Cai, L. L., Niehues, M., Badock, V., et al. (2020) · Nature Chemical Biology · doi:10.1038/s41589-020-0501-5 · Cited by 489
Occupational exposures to metals as risk factors for Parkinson's disease
Gorell, J. M., Johnson, C. C., Rybicki, B. A., Peterson, E. L., Kortsha, G. X., Brown, G. G., & Richardson, R. J. (1997) · Neurology · doi:10.1212/wnl.48.3.650 · Cited by 476
Zhang, Z., Yao, Z., Wang, L., Ding, H., Shao, J., Chen, A., Zhang, F., & Zheng, S. (2018) · Autophagy · doi:10.1080/15548627.2018.1503146 · Cited by 474
Ferroptosis and Its Role in Diverse Brain Diseases
Weiland, A., Wang, Y., Wu, W., Lan, X., Han, X., Li, Q., & Wang, J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1403-3 · Cited by 467
Zhang, Z., Guo, M., Li, Y., Shen, M., Kong, D., Shao, J., Ding, H., Tan, S., Chen, A., Zhang, F., et al. (2020) · Autophagy · doi:10.1080/15548627.2019.1687985 · Cited by 462
The Role of Erastin in Ferroptosis and Its Prospects in Cancer Therapy
Zhao, Y., Li, Y., Zhang, R., Wang, F., Wang, T., & Jiao, Y. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s254995 · Cited by 458
Masaldan, S., Clatworthy, S. A. S., Gamell, C., Meggyesy, P. M., Rigopoulos, A.-T., Haupt, S., Haupt, Y., Denoyer, D., Adlard, P. A., Bush, A. I., et al. (2018) · Redox Biology · doi:10.1016/j.redox.2017.08.015 · Cited by 452
A delicate balance: Iron metabolism and diseases of the brain
Hare, D., Ayton, S., Bush, A., & Lei, P. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00034 · Cited by 443
The chemistry and biology of ferroptosis
Stockwell, B. R., & Jiang, X. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.03.013 · Cited by 429 · cited 1×
“Lipid peroxidation is the trigger for the activation of ferroptosis [13,18].”
BackgroundMeister, A. (1995) · Methods in Enzymology · doi:10.1016/0076-6879(95)51106-7 · Cited by 428
Targeting Nrf2 to Suppress Ferroptosis and Mitochondrial Dysfunction in Neurodegeneration
Abdalkader, M., Lampinen, R., Kanninen, K. M., Malm, T. M., & Liddell, J. R. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00466 · Cited by 423
Hypoxia inhibits ferritinophagy, increases mitochondrial ferritin, and protects from ferroptosis
Fuhrmann, D. C., Mondorf, A., Beifuß, J., Jung, M., & Brüne, B. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101670 · Cited by 405
Martin-Bastida, A., Ward, R. J., Newbould, R., Piccini, P., Sharp, D., Kabba, C., Patel, M. C., Spino, M., Connelly, J., Tricta, F., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01402-2 · Cited by 379
Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer
Roh, J.-L., Kim, E. H., Jang, H. J., Park, J. Y., & Shin, D. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.07.035 · Cited by 373
Stoyanovsky, D. A., Tyurina, Y. Y., Shrivastava, I., Bahar, I., Tyurin, V. A., Protchenko, O., Jadhav, S., Bolevich, S. B., Kozlov, A. V., Vladimirov, Y. A., et al. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.09.008 · Cited by 368
Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology
Ayton, S., Wang, Y., Diouf, I., Schneider, J. A., Brockman, J., Morris, M. C., & Bush, A. I. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0375-7 · Cited by 365
Dysregulation of Glutathione Homeostasis in Neurodegenerative Diseases
Johnson, W. M., Wilson-Delfosse, A. L., & Mieyal, J. J. (2012) · Nutrients · doi:10.3390/nu4101399 · Cited by 353
Ferroptosis and cell death mechanisms in Parkinson's disease
Guiney, S. J., Adlard, P. A., Bush, A. I., Finkelstein, D. I., & Ayton, S. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.01.004 · Cited by 338
An update on lipid oxidation and inflammation in cardiovascular diseases
Zhong, S., Li, L., Shen, X., Li, Q., Xu, W., Wang, X., Tao, Y., & Yin, H. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.03.036 · Cited by 332
[Epidemiology of Parkinson disease].
Domínguez Carmona, M. (1989) · PubMed · Cited by 330
Achieving Life through Death: Redox Biology of Lipid Peroxidation in Ferroptosis
Bayır, H., Anthonymuthu, T. S., Tyurina, Y. Y., Patel, S. J., Amoscato, A. A., Lamade, A. M., Yang, Q., Vladimirov, G. K., Philpott, C. C., & Kagan, V. E. (2020) · Cell Chemical Biology · doi:10.1016/j.chembiol.2020.03.014 · Cited by 317
Going the Extra (Synaptic) Mile: Excitotoxicity as the Road Toward Neurodegenerative Diseases
Armada-Moreira, A., Gomes, J. I., Pina, C. C., Savchak, O. K., Gonçalves-Ribeiro, J., Rei, N., Pinto, S., Morais, T. P., Martins, R. S., Ribeiro, F. F., et al. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00090 · Cited by 317
Labile iron in cells and body fluids: Physiology, pathology, and pharmacology
Cabantchik, Z. I. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00045 · Cited by 306 · cited 1×
“The storage of labile iron in ferritin serves to prevent its high reactivity, avoiding the generation of reactive species [94].”
BackgroundNovel pharmacological targets for the treatment of Parkinson's disease
Schapira, A. H. V., Bezard, E., Brotchie, J., Calon, F., Collingridge, G. L., Ferger, B., Hengerer, B., Hirsch, E., Jenner, P., Novère, N. L., et al. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2087 · Cited by 298
Alpha synuclein aggregation drives ferroptosis: an interplay of iron, calcium and lipid peroxidation
Angelova, P. R., Choi, M. L., Berezhnov, A. V., Horrocks, M. H., Hughes, C. D., De, S., Rodrigues, M., Yapom, R., Little, D., Dolt, K. S., et al. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-020-0542-z · Cited by 296
Dexter, D. T., Jenner, P., Schapira, A. H. V., Marsden, C. D., & The Royal Kings and Queens Parkinson's Disease Research Group (1992) · Annals of Neurology · doi:10.1002/ana.410320716 · Cited by 292
Cell death pathways in Parkinson’s disease: proximal triggers, distal effectors, and final steps
Levy, O. A., Malagelada, C., & Greene, L. A. (2009) · Apoptosis · doi:10.1007/s10495-008-0309-3 · Cited by 287
Glutathione peroxidase 4: a new player in neurodegeneration?
Cardoso, B. R., Hare, D. J., Bush, A. I., & Roberts, B. R. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.196 · Cited by 281
MDM2 and MDMX promote ferroptosis by PPARα-mediated lipid remodeling
Venkatesh, D., O'Brien, N. A., Zandkarimi, F., Tong, D. R., Stokes, M. E., Dunn, D. E., Kengmana, E. S., Aron, A. T., Klein, A. M., Csuka, J. M., et al. (2020) · Genes & Development · doi:10.1101/gad.334219.119 · Cited by 274
Ferroptosis and Its Potential Role in Human Diseases
Han, C., Liu, Y., Dai, R., Ismail, N., Su, W., & Li, B. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00239 · Cited by 273
Habib, E., Linher-Melville, K., Lin, H.-X., & Singh, G. (2015) · Redox Biology · doi:10.1016/j.redox.2015.03.003 · Cited by 271
The function and mechanism of ferroptosis in cancer
Wang, Y., Wei, Z., Pan, K., Li, J., & Chen, Q. (2020) · Apoptosis · doi:10.1007/s10495-020-01638-w · Cited by 263
Kim, E. H., Shin, D., Lee, J., Jung, A. R., & Roh, J.-L. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.06.018 · Cited by 261
Evolutionary and Structural Insights Into the Multifaceted Glutathione Peroxidase (Gpx) Superfamily
Toppo, S., Vanin, S., Bosello, V., & Tosatto, S. C. E. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2057 · Cited by 259
Dar, H. H., Tyurina, Y. Y., Mikulska-Ruminska, K., Shrivastava, I., Ting, H.-C., Tyurin, V. A., Krieger, J., St. Croix, C. M., Watkins, S., Bayir, E., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99490 · Cited by 251
Iron Metabolism, Ferroptosis, and the Links With Alzheimer’s Disease
Yan, N., & Zhang, J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01443 · Cited by 251
Ballatori, N., Hammond, C. L., Cunningham, J. B., Krance, S. M., & Marchan, R. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.09.008 · Cited by 247
Kalinina, E. V., Chernov, N. N., & Novichkova, M. D. (2014) · Biochemistry (Moscow) · doi:10.1134/s0006297914130082 · Cited by 245
Glutathione redox imbalance in brain disorders
Gu, F., Chauhan, V., & Chauhan, A. (2015) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0000000000000134 · Cited by 236
Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence
Graham, J. M. (2000) · Brain · doi:10.1093/brain/123.12.2423 · Cited by 223
Zhou, Z. D., & Tan, E.-K. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0218-4 · Cited by 222
Yu, H., Yang, C., Jian, L., Guo, S., Chen, R., Li, K., Qu, F., Tao, K., Fu, Y., Luo, F., et al. (2019) · Oncology Reports · doi:10.3892/or.2019.7189 · Cited by 222
Alzheimer´s Disease and Oxidative Stress: A Review
Pohanka, M. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113206660258 · Cited by 218
The role of glutamate in neuronal ischemic injury: the role of spark in fire
Kostandy, B. B. (2012) · Neurological Sciences · doi:10.1007/s10072-011-0828-5 · Cited by 214
Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex
Rees, T. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00230-0 · Cited by 207
Ferroptosis as an emerging target in inflammatory diseases
Mao, H., Zhao, Y., Li, H., & Lei, L. (2020) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2020.04.001 · Cited by 203
Hu, C., Nydes, M., Shanley, K. L., Morales Pantoja, I. E., Howard, T. A., & Bizzozero, O. A. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14604 · Cited by 200
Mammalian arachidonate 15-lipoxygenases
Kuhn, H., Walther, M., & Kuban, R. J. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00035-7 · Cited by 199
Wild, A. C., & Mulcahy, R. T. (2000) · Free Radical Research · doi:10.1080/10715760000300291 · Cited by 197
Induction of ferroptosis and mitochondrial dysfunction by oxidative stress in PC12 cells
Wu, C., Zhao, W., Yu, J., Li, S., Lin, L., & Chen, X. (2018) · Scientific Reports · doi:10.1038/s41598-017-18935-1 · Cited by 194
Hasegawa, M., Takahashi, H., Rajabi, H., Alam, M., Suzuki, Y., Yin, L., Tagde, A., Maeda, T., Hiraki, M., Sukhatme, V. P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7598 · Cited by 191
Selenium and GPX4, a vital symbiosis
Friedmann Angeli, J. P., & Conrad, M. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.03.001 · Cited by 191
Cellular regulation and molecular interactions of the ferritins
Hintze, K. J., & Theil, E. C. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5285-y · Cited by 187
The transcription factor NF‐E2‐related Factor 2 (Nrf2): a protooncogene?
Shelton, P., & Jaiswal, A. K. (2013) · The FASEB Journal · doi:10.1096/fj.12-217257 · Cited by 186
Disorders of Human Coenzyme Q10 Metabolism: An Overview
Hargreaves, I., Heaton, R. A., & Mantle, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186695 · Cited by 182
Yao, X., Feng, S.-Q., Fan, B.-Y., Pang, Y.-L., Li, W.-X., Zhao, C.-X., Zhang, Y., Wang, X., Ning, G.-Z., Kong, X.-H., et al. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.293157 · Cited by 180
Klepac, N., Relja, M., Klepac, R., Hećimović, S., Babić, T., & Trkulja, V. (2007) · Journal of Neurology · doi:10.1007/s00415-007-0611-y · Cited by 178
Regulated cell death and adaptive stress responses
Galluzzi, L., Bravo-San Pedro, J. M., Kepp, O., & Kroemer, G. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2209-y · Cited by 177
Duodenal Cytochrome b (DCYTB) in Iron Metabolism: An Update on Function and Regulation
Lane, D. J. R., Bae, D.-H., Merlot, A. M., Sahni, S., & Richardson, D. R. (2015) · Nutrients · doi:10.3390/nu7042274 · Cited by 177
Parkinson’s Disease Psychosis: Presentation, Diagnosis and Management
Schneider, R. B., Iourinets, J., & Richard, I. H. (2017) · Neurodegenerative Disease Management · doi:10.2217/nmt-2017-0028 · Cited by 177
Glutathione peroxidase 4 (Gpx4) and ferroptosis: what's so special about it?
Conrad, M., & Friedmann Angeli, J. P. (2015) · Molecular & Cellular Oncology · doi:10.4161/23723556.2014.995047 · Cited by 176
Iron Accumulates in Huntington’s Disease Neurons: Protection by Deferoxamine
Chen, J., Marks, E., Lai, B., Zhang, Z., Duce, J. A., Lam, L. Q., Volitakis, I., Bush, A. I., Hersch, S., & Fox, J. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077023 · Cited by 174
Mammalian Arachidonate 12-Lipoxygenases
Yamamoto, S., Takahashi, Y., Hada, T., Hagiya, H., Suzuki, H., Reddy, G. R., Ueda, N., Arakawa, T., Nakamura, M., Matsuda, S., et al. (1997) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4615-5325-0_18 · Cited by 172
Steap Proteins: Implications for Iron and Copper Metabolism
Knutson, M. D. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2007.tb00311.x · Cited by 171
Evolution of the iron-responsive element
Piccinelli, P., & Samuelsson, T. (2007) · RNA · doi:10.1261/rna.464807 · Cited by 168
Magtanong, L., & Dixon, S. J. (2018) · Developmental Neuroscience · doi:10.1159/000496922 · Cited by 167
Ceruloplasmin in neurodegenerative diseases
Vassiliev, V. B., Harris, Z. L., & Zatta, P. F. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.03.003 · Cited by 166
Sun, Y., He, L., Wang, T., Hua, W., Qin, H., Wang, J., Wang, L., Gu, W., Li, T., Li, N., et al. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02049-3 · Cited by 164
Huntington disease: A single-gene degenerative disorder of the striatum
Nopoulos, P. C. (2016) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2016.18.1/pnopoulos · Cited by 161
Alterations in Brain Transition Metals in Huntington Disease: An Evolving and Intricate Story
Rosas, H. D., Chen, Y. I., Doros, G., Salat, D. H., Chen, N.-K., Kwong, K. K., Bush, A., Fox, J., & Hersch, S. M. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.2945 · Cited by 160
DeGregorio-Rocasolano, N., Martí-Sistac, O., & Gasull, T. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00085 · Cited by 158
Li, Y., Yan, H., Xu, X., Liu, H., Wu, C., & Zhao, L. (2019) · Oncology Letters · doi:10.3892/ol.2019.11066 · Cited by 158
Sigma‐1 receptor protects against ferroptosis in hepatocellular carcinoma cells
Bai, T., Lei, P., Zhou, H., Liang, R., Zhu, R., Wang, W., Zhou, L., & Sun, Y. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14594 · Cited by 154
Ates, G., Goldberg, J., Currais, A. J. M., & Maher, P. A. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101648 · Cited by 149
Physiological role of phospholipid hydroperoxide glutathione peroxidase in mammals
Conrad, M., Schneider, M., Seiler, A., & Bornkamm, G. W. (2007) · Biological Chemistry · doi:10.1515/bc.2007.130 · Cited by 136
Lv, H., & Shang, P. (2018) · Metallomics · doi:10.1039/c8mt00048d · Cited by 129
Genetic architecture of Alzheimer's disease
Neuner, S. M., TCW, J., & Goate, A. M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104976 · Cited by 126
Dedman, D., Treffry, A., Candy, J., Taylor, G. A., Morris, C. M., Bloxham, C. A., Perry, R. H., Edwardson, J. A., & Harrison, P. M. (1992) · Biochemical Journal · doi:10.1042/bj2870509 · Cited by 121
Iron Homeostasis: Fitting the Puzzle Pieces Together
Ganz, T. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.03.008 · Cited by 121
The Emerging Roles of Ferroptosis in Huntington’s Disease
Mi, Y., Gao, X., Xu, H., Cui, Y., Zhang, Y., & Gou, X. (2019) · NeuroMolecular Medicine · doi:10.1007/s12017-018-8518-6 · Cited by 121
Hexokinases link DJ-1 to the PINK1/parkin pathway
Hauser, D. N., Mamais, A., Conti, M. M., Primiani, C. T., Kumaran, R., Dillman, A., Langston, R. G., Beilina, A. G., Garcia, J. H., Díaz‐Ruiz, A., et al. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0212-x · Cited by 114
Maher, P. A. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.11.015 · Cited by 112
Genetics of iron regulation and the possible role of iron in Parkinson's disease
Rhodes, S. L., & Ritz, B. R. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.07.001 · Cited by 110
Hou, L., Huang, R., Sun, F., Zhang, L., & Wang, Q. (2019) · Toxicology · doi:10.1016/j.tox.2019.02.011 · Cited by 109
Cong, L., Dong, X., Wang, Y., Deng, Y., Li, B., & Dai, R. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.01.039 · Cited by 106
Ceruloplasmin activity and iron chelation treatment of patients with Parkinson’s disease
Grolez, G., Moreau, C., Sablonnière, B., Garçon, G., Devedjian, J.-C., Meguig, S., Gelé, P., Delmaire, C., Bordet, R., Defebvre, L., et al. (2015) · BMC Neurology · doi:10.1186/s12883-015-0331-3 · Cited by 103
Jarvik, L. F., & Alzheimer, A. (1987) · PubMed · Cited by 101
Wang, S., Chen, M.-S., Chou, Y., Ueng, Y., Yin, P., Yeh, T.-S., & Lee, H. (2016) · Oncotarget · doi:10.18632/oncotarget.12356 · Cited by 100
Treating Alzheimer's disease by targeting iron
Nikseresht, S., Bush, A. I., & Ayton, S. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14567 · Cited by 100
Tsatsanis, A., Wong, B. X. W., Gunn, A. P., Ayton, S., Bush, A. I., Devos, D., & Duce, J. A. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0762-0 · Cited by 97
Antiferroptotic activity of non-oxidative dopamine
Wang, D., Peng, Y., Xie, Y., Zhou, B., Sun, X., Kang, R., & Tang, D. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.10.099 · Cited by 91
Gunesch, S., Hoffmann, M., Kiermeier, C., Fischer, W. H., Pinto, A. F. M., Maurice, T., Maher, P. A., & Decker, M. W. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101378 · Cited by 89
THE NON‐HAEMIN IRON IN THE CEREBRAL CORTEX IN ALZHEIMER'S DISEASE
Hallgren, B., & Sourander, P. (1960) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1960.tb13369.x · Cited by 88
Anthonymuthu, T. S., Kenny, E., Shrivastava, I. H., Tyurina, Y. Y., Hier, Z. E., Ting, H.-C., Dar, H. H., Tyurin, V. A., Nesterova, A., Amoscato, A. A., et al. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b09913 · Cited by 87
Vučković, A., Bosello-Travain, V., Bordin, L., Cozza, G., Miotto, G., Rossetto, M., Toppo, S., Venerando, R., Zaccarin, M., Maiorino, M., et al. (2019) · FEBS Letters · doi:10.1002/1873-3468.13631 · Cited by 87
Ferroptosis is newly characterized form of neuronal cell death in response to arsenite exposure
Tang, Q., Bai, L., Zou, Z., Meng, P., Xia, Y., Cheng, S., Mu, S., Zhou, J., Wang, X., Qin, X., et al. (2018) · NeuroToxicology · doi:10.1016/j.neuro.2018.04.012 · Cited by 86
Iron Exposure and the Cellular Mechanisms Linked to Neuron Degeneration in Adult Mice
Li, L.-B., Chai, R., Zhang, S., Xu, S., Zhang, Y., Li, H., Fan, Y., & Guo, C. (2019) · Cells · doi:10.3390/cells8020198 · Cited by 86
Hepcidin: Homeostasis and Diseases Related to Iron Metabolism
Reichert, C. O., da Cunha, J., Levy, D., Maselli, L. M. F., Bydlowski, S. P., & Spada, C. (2017) · Acta Haematologica · doi:10.1159/000471838 · Cited by 84
Self-citationBorchert, A., Kalms, J., Roth, S. R., Rademacher, M., Schmidt, A., Holzhütter, H., Kühn, H., & Scheerer, P. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.06.006 · Cited by 83
Fischer, W. H., Currais, A. J. M., Liang, Z., Pinto, A. F. M., & Maher, P. A. (2018) · Redox Biology · doi:10.1016/j.redox.2018.101089 · Cited by 83
Yang, Y.-W., Liou, S.-H., Hsueh, Y.-M., Lyu, W.-S., Liu, C.-S., Liu, H.-J., Chung, M.-C., Hung, P.-H., & Chung, C.-J. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.07.015 · Cited by 82
Chu, F. (2008) · Cytogenetics and Cell Genetics · doi:10.1159/000133675 · Cited by 81
Spotlight on Ferroptosis: Iron-Dependent Cell Death in Alzheimer’s Disease
Ashraf, A., & So, P. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00196 · Cited by 81
Crosstalk between Nrf2 signaling and mitochondrial function in Parkinson's disease
Kaidery, N. A., Ahuja, M., & Thomas, B. (2019) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2019.103413 · Cited by 80
Nonmotor fluctuations in Parkinson's disease: Clinical spectrum and classification
Bayülkem, K., & Lopez, G. J. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.08.022 · Cited by 75
Structure–activity Relationships of Glutathione Peroxidase 4 Inhibitor Warheads
Eaton, J. K., Furst, L., Cai, L. L., Viswanathan, V. S., & Schreiber, S. L. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127538 · Cited by 73
Targeting the NF-E2-Related Factor 2 Pathway: a Novel Strategy for Traumatic Brain Injury
Zhang, L., & Wang, H. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0456-z · Cited by 69
Shi, L., Huang, C., Luo, Q., Xia, Y., Liu, W., Zeng, W., Cheng, A., Shi, R., & Zhengli, C. (2020) · Aging · doi:10.18632/aging.103225 · Cited by 66
Paraoxonases Activities and Polymorphisms in Elderly and Old-Age Diseases: An Overview
Levy, D., Reichert, C. O., & Bydlowski, S. P. (2019) · Antioxidants · doi:10.3390/antiox8050118 · Cited by 65
Self-citationHirata, Y., Yamada, C., Ito, Y., Yamamoto, S., Nagase, H., Oh‐hashi, K., Kiuchi, K., Suzuki, H., Sawada, M., & Furuta, K. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.03.015 · Cited by 63
Iron stored in ferritin is chemically reduced in the presence of aggregating Aβ(1-42)
Everett, J. L., Brooks, J., Lermyte, F., O’Connor, P. B., Sadler, P. J., Dobson, J., Collingwood, J. F., & Telling, N. D. (2020) · Scientific Reports · doi:10.1038/s41598-020-67117-z · Cited by 60
Xu, Y. X., Zhang, Y., Zhang, J.-H., Han, K., Zhang, X., Bai, X., You, L., Yu, P., Shi, Z., Chang, Y.-Z., et al. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.07.012 · Cited by 58
Yagami, T., Yamamoto, Y., & Koma, H. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1277-4 · Cited by 56
Recent Overview of the Use of iPSCs Huntington’s Disease Modeling and Therapy
Csöbönyeiová, M., Polák, Š., & Danišovič, Ľ. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062239 · Cited by 55
Clinical MRI for iron detection in Parkinson's disease
Rossi, M. E., Ruottinen, H., Soimakallio, S., Elovaara, I., & Dastidar, P. (2013) · Clinical Imaging · doi:10.1016/j.clinimag.2013.02.001 · Cited by 52
Errors in Huntington disease diagnostic test caused by trinucleotide deletion in the IT15 gene.
Gellera, C., Meoni, C., Castellotti, B., Zappacosta, B., Girotti, F., Taroni, F., & DiDonato, S. (1996) · PubMed Central · Cited by 51
Bortolami, M., Pandolfi, F., Vita, D. D., Carafa, C., Messore, A., Santo, R. D., Feroci, M., Costi, R., Chiarotto, I., Bagetta, D., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112350 · Cited by 50
Redox (phospho)lipidomics of signaling in inflammation and programmed cell death
Tyurina, Y. Y., Croix, C. M. S., Watkins, S. C., Watson, A. M., Epperly, M. W., Anthonymuthu, T. S., Kisin, E. R., Vlasova, I. I., Krysko, O., Krysko, D. V., et al. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mir0119-004rr · Cited by 49
Systems biology of ferroptosis: A modeling approach
Konstorum, A., Tesfay, L., Paul, B. T., Torti, F. M., Laubenbacher, R., & Torti, S. V. (2020) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2020.110222 · Cited by 46
Ironing out Parkinson's disease: is therapeutic treatment with iron chelators a real possibility?
Kaur, D., & Andersen, J. K. (2002) · Aging Cell · doi:10.1046/j.1474-9728.2002.00001.x · Cited by 44
Huntington's Disease: Advocacy Driving Science
Wexler, N. S. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-050710-134457 · Cited by 44
Cited by
GPX4: The hub of lipid oxidation, ferroptosis, disease and treatment
Liu, Y., Wan, Y., Jiang, Y., Zhang, L., & Cheng, W. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188890 · Cited by 528
Understanding the complexity of p53 in a new era of tumor suppression
Liu, Y., Su, Z., Tavana, O., & Gu, W. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.04.009 · Cited by 495
Identification of essential sites of lipid peroxidation in ferroptosis
von Krusenstiern, A. N., Robson, R. N., Qian, N., Qiu, B., Hu, F., Reznik, E., Smith, N., Zandkarimi, F., Estes, V. M., Dupont, M., et al. (2023) · Nature Chemical Biology · doi:10.1038/s41589-022-01249-3 · Cited by 413
Molecular mechanisms of ferroptosis and their involvement in brain diseases
Costa, I., Barbosa, D. J., Benfeito, S., Silva, V., Chavarria, D., Borges, F., Remião, F., & Silva, R. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108373 · Cited by 402
Therapeutic application of quercetin in aging-related diseases: SIRT1 as a potential mechanism
Cui, Z., Zhao, X., Amevor, F. K., Du, X., Wang, Y., Li, D., Shu, G., Tian, Y., & Zhao, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.943321 · Cited by 377
Metadata
- Authors
- Reichert, C. O., de Freitas, F. A., Sampaio-Silva, J., Rokita-Rosa, L., Barros, P. D. L., Levy, D., & Bydlowski, S. P.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-11-20
- Volume
- 21
- Issue
- 22
- Pages
- 8765
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3104467474
- Cited by
- 422
- References
- 225
- FWCI
- 23.77
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.